In addition, the mTOR pathway also enhances aerobic glycolysis by upregulating PKM2 via c-Myc induction [28], suggesting that inhibition of the mTOR pathway by pharmacological components (such as RapaLinks [29]) might have therapeutic importance in cancer treatment. This evidence concerns the gene PKM and cancer.